Skip to main content

David M WangMichelangelo VestitaFadi G MuradFrederick C MorganRachael RowleyEleni M RettigWilliam LotterAbigail B WaldmanEmily S RuizChrysalyne D Schmults

Abstract

Importance: High-stage cutaneous squamous cell carcinoma (cSCC) has an increased risk of recurrence, metastasis, and mortality. Studies investigating the outcomes of high-stage cSCC among patients treated with Mohs surgery compared with those treated with wide local excision (WLE) are limited.

Objective: To assess the outcomes of primary high-stage cSCC among patients treated with Mohs surgery compared with those treated with WLE.

Design, setting, and participants: This retrospective cohort study using propensity score weighting was conducted in a tertiary academic medical center in Boston, Massachusetts. Patients were included if they had primary high-stage cSCC and had been treated with either Mohs surgery or WLE between January 1, 2000, and December 31, 2019. Data analysis was performed between November 3 and 6, 2023.

Exposures: Primary surgical treatment with Mohs surgery or WLE.

To read this article further please click here.

MoleMax Systems
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.